CAS: 2247240-76-0
![4-(dimethylamino)-N-[3-[[2-[(4-oxo-4H-1-benzopyran-7-yl)oxy]acetyl]amino]phenyl]-benzamide](https://static.cymitquimica.com/products/IN/thumb/DA01LIH8.jpg)
4-(dimethylamino)-N-[3-[[2-[(4-oxo-4H-1-benzopyran-7-yl)oxy]acetyl]amino]phenyl]-benzamide
CAS:2247240-76-0
Formula:
C26H23N3O5
Purity:
98%
Molecular weight:
457.4779
Ref: IN-DA01LIH8
| 1mg | 214.00 € | ||
| 5mg | 599.00 € | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
![4-(Dimethylamino)-N-[3-[[2-[(4-oxo-4H-1-benzopyran-7-yl)oxy]acetyl]amino]phenyl]-benzamide](https://static.cymitquimica.com/products/3D/thumb/XPD24076.jpg)
4-(Dimethylamino)-N-[3-[[2-[(4-oxo-4H-1-benzopyran-7-yl)oxy]acetyl]amino]phenyl]-benzamide
CAS:2247240-76-0
Please enquire for more information about 4-(Dimethylamino)-N-[3-[[2-[(4-oxo-4H-1-benzopyran-7-yl)oxy]acetyl]amino]phenyl]-benzamide including the price, delivery time and more detailed …
Formula:
C26H29N3O5
Purity:
Min. 95%
Molecular weight:
463.5 g/mol
Ref: 3D-XPD24076
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
CAY10746
CAS:2247240-76-0
CAY10746 selectively inhibits ROCK I/II with IC50s: 0.014/0.003 μM, useful for diabetic retinopathy research.
Formula:
C26H23N3O5
Purity:
99.04%
Color and Shape:
Solid
Molecular weight:
457.48
Ref: TM-T36196
| 1mg | 52.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 184.00 € | ||
| 25mg | 423.00 € | ||
| 50mg | 640.00 € | ||
| 100mg | 1,012.00 € | ||
| 200mg | 1,368.00 € | ||
| 1mL*10mM (DMSO) | 119.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
